Ensysce Biosciences, Inc. · NASDAQ:ENSC
Bob Gene Gower bought 908,614 Ensysce Biosciences, Inc. shares (Form 4)
Traded Apr 23 to Aug 7, 2026 · Filed Aug 18, 2026
From Apr 23 to Aug 7, 2026, Bob Gene Gower (Director) bought 908,614 Ensysce Biosciences, Inc. shares at an average US$0.49 for US$444K, leaving 916,740 shares. Filed Aug 18, 2026 (Form 4).
- Bought
- 908,614 shares
- Price
- US$0.49 average (US$0.48 to US$0.50)
- Value
- US$444K
- Holding after
- 916,740 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock | Buy | 508,614 | US$0.48 | 516,740 | Direct |
| Aug 7, 2026 | Common Stock | Buy | 400,000 | US$0.50 | 916,740 | Direct |
Source
Related
- Ensysce Biosciences, Inc.
- Bob Gene Gower
- Ensysce Biosciences, Inc. shareholders
- Schedule 13D/A · Bob Gene Gower · Aug 18, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2025
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2025
- Schedule 13G · Adage Capital Management, L.P. · May 12, 2025
- Schedule 13G/A · Perceptive Advisors LLC · Apr 3, 2025